NovoCure Limited on November 24, 2025 by mutual agreement, Ashley Cordova, Director and Chief Executive Officer resigned as a member of the Board of Directors, effective immediately, and her position as Chief Executive Officer of the Company, effective November 30, 2025. There was no disagreement with the Company known to an executive officer of the Company on any matter relating to the Company?s operations, policies or practices in connection with Ms. Cordova?s departure from the Company?s Board of Directors, nor has Ms. Cordova been removed from the Board of Directors for cause. On December 1, 2025, the Company announced the appointment of Frank Leonard, age 46, who is currently serving as the Company?s President, as the Chief Executive Officer of the Company and its respective direct and indirect subsidiaries and affiliates (together, the ?Novocure Group?), effective December 1, 2025.
Mr. Leonard was named the company?s President in June 2025. He was responsible for Novocure?s global business operations, which he led since January 2024, and was responsible for sales, marketing, field medical affairs, patient experience, public affairs, market access, and product and portfolio strategy functions. Mr. Leonard previously led our US business, beginning in October 2022.
Mr. Leonard served as Chief Development Officer of the Company from September 2020 to September 2022, and was responsible for engineering, product development, business development and the overall strategic and operational leadership of the Company?s innovation platforms. He joined the Company in 2010 to prepare the company for a commercial launch and held various roles establishing the Company?s finance, reimbursement, and business development functions. Prior to joining the Company, Mr. Leonard was a venture capital investor focused on high-impact medical technology companies, including Novocure. He has served as a director of the Medical Device Manufacturers Association (MDMA) since 2023.
Mr. Leonard received an A.B. from Harvard University in 2001 and an M.A. from the London School of Economics and Political Science in 2004.
